Close

More on MIRM

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+47.5% Growth)
- Ratings (10.0 Score)
- Holders

Upcoming Events

- Earnings (5/2/24)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Mirum Pharmaceuticals, Inc. (NQ:MIRM)
Delayed: 24.02 -0.4 (1.64%)
Prev. Close $24.42  
Open$24.93 
52 Wk High$ 
52 Wk Low$ 
Day High$24.93 
Day Low$23.85 
P/E N/A  
EPS$ 
Volume317,121 

Friends, Peers and Foes (?): TVTX, IPSC, RPHM, CNTB, THAR (more...)

Apr 23, 2024 04:31 PM Form ARS Mirum Pharmaceuticals, For: Dec 31
Apr 23, 2024 04:22 PM Form DEFA14A Mirum Pharmaceuticals,
Apr 23, 2024 04:20 PM Form DEF 14A Mirum Pharmaceuticals, For: Apr 23
Apr 16, 2024 04:07 PM Stifel Starts Mirum Pharamceuticals (MIRM) at Buy
Apr 16, 2024 04:53 AM Citi Opens 90-Day Upside Catalyst Watch on Mirum Pharamceuticals (MIRM)
Apr 10, 2024 09:30 PM Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 2, 2024 08:33 AM Mirum Pharmaceuticals' (MIRM) LIVMARLI Receives Positive Reimbursement Recommendation by Canada’s CADTH
Apr 2, 2024 08:30 AM Mirum Pharmaceuticals’ LIVMARLI (maralixibat oral solution) Receives Positive Reimbursement Recommendation by Canada’s CADTH for Patients with Cholestatic Pruritus in Alagille Syndrome
Mar 27, 2024 08:48 PM Form 4 Mirum Pharmaceuticals, For: Mar 27 Filed by: BJERKHOLT ERIC
Mar 25, 2024 05:42 PM Form 4 Mirum Pharmaceuticals, For: Mar 25 Filed by: Radovich Peter
View All Articles

Entities mentioned with MIRM

View All Entities